RecruitingPhase 3NCT07011732
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
Sponsor: Bristol-Myers Squibb
Columbia, SC · +40 more sites
2 recruiting alzheimer's disease studies with a site in Columbia, SC.
Sponsor: Bristol-Myers Squibb
Columbia, SC · +40 more sites
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Columbia, SC · +101 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.